BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+8.78%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$557M
AUM Growth
+$557M
(-6.3%)
Cap. Flow
-$47.1M
Cap. Flow
% of AUM
-8.44%
Top 10 Holdings %
Top 10 Hldgs %
53.94%
Holding
54
New
12
Increased
14
Reduced
12
Closed
8
Top Buys
| 1 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$15.2M |
| 2 |
Xenon Pharmaceuticals
XENE
|
$11.8M |
| 3 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$11.3M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$8.41M |
| 5 |
Pacific Biosciences
PACB
|
$7.78M |
Top Sells
Sector Composition
| 1 | Healthcare | 88.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Iovance Biotherapeutics
IOVA
$807M
| $55.1M | 8.1% | 4,894,361 +747,756 | +18% | +$8.41M |
|
|
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $41.3M | 6.08% | 2,053,991 +559,471 | +37% | +$11.3M |
|
|
ZGNX
3
DELISTED
Zogenix, Inc.
ZGNX
| $32.6M | 4.8% | 657,898 +35,518 | +6% | +$1.76M |
|
4
ADMA Biologics
ADMA
$4.12B
| $27.7M | 4.08% | 4,463,829 +1,214,000 | +37% | +$7.54M |
|
5
Travere Therapeutics
TVTX
$1.56B
| $27M | 3.97% | 938,214 -110,479 | -11% | -$3.17M |
|
|
ADMS
6
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $26.6M | 3.91% | 1,328,424 -88,697 | -6% | -$1.78M |
|
7
Tandem Diabetes Care
TNDM
$845M
| $24.6M | 3.61% | 573,079 +2,481 | +0.4% | +$106K |
|
|
PETX
8
DELISTED
Aratana Therapeutics, Inc.
PETX
| $23.8M | 3.51% | 4,083,135 -211,291 | -5% | -$1.23M |
|
|
CORI
9
DELISTED
Corium International, Inc.
CORI
| $22.5M | 3.31% | 2,368,557 -1,228,500 | -34% | -$11.7M |
|
10
Catalyst Pharmaceutical
CPRX
$2.52B
| $19.4M | 2.86% | 5,136,264 -1,636,500 | -24% | -$6.19M |
|
|
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $16.8M | 2.48% | 357,672 -662,506 | -65% | -$31.2M |
|
|
ATRS
12
DELISTED
Antares Pharma, Inc.
ATRS
| $15.5M | 2.29% | 4,623,247 | – | – |
|
|
NSTG
13
DELISTED
NanoString Technologies, Inc.
NSTG
| $15.2M | 2.23% | +850,000 | New | +$15.2M |
|
|
SCTL
14
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $14.6M | 2.14% | 2,048,025 | – | – |
|
|
15
Pacific Biosciences
PACB
$393M
| $13.5M | 1.98% | 2,493,021 +1,438,930 | +137% | +$7.78M |
|
16
Integra LifeSciences
IART
$1.18B
| $12.9M | 1.91% | 196,572 +33,148 | +20% | +$2.18M |
|
|
SBBP
17
DELISTED
Strongbridge Biopharma plc.
SBBP
| $12.4M | 1.83% | 2,563,096 +222,447 | +10% | +$1.08M |
|
|
AVDL
18
Avadel Pharmaceuticals
AVDL
$1.43B
| $12.3M | 1.8% | 2,792,773 +68,110 | +2% | +$299K |
|
|
BDSI
19
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $12.3M | 1.8% | 4,375,066 +96,247 | +2% | +$269K |
|
|
TLGT
20
DELISTED
Teligent, Inc
TLGT
| $12.1M | 1.77% | 3,052,852 +53,035 | +2% | +$209K |
|
|
21
Xenon Pharmaceuticals
XENE
$2.98B
| $11.8M | 1.74% | +895,553 | New | +$11.8M |
|
22
Heron Therapeutics
HRTX
$207M
| $9.22M | 1.36% | 291,213 -228,574 | -44% | -$7.23M |
|
|
HZNP
23
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $8.04M | 1.18% | 410,532 -929,043 | -69% | -$18.2M |
|
24
Strata Skin Sciences
SSKN
$9.93M
| $7.72M | 1.14% | 2,181,363 -762,456 | -26% | -$2.7M |
|
|
SRRA
25
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $6.95M | 1.02% | 4,090,344 +1,983,755 | +94% | +$3.37M |
|